Clinical trial
A Prospective, Single-Center, Observational Cohort Study of Thiotepa-Based Conditioning in Older Participants With Severe or Very Severe Aplastic Anemia Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
NCT07819812 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Single-Center, Observational Cohort Study of Thiotepa-Based Conditioning in Older Participants With Severe or Very Severe Aplastic Anemia Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
- Lead sponsor
- Peking University People's Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 20, 2026
- Completion date
- December 31, 2028
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hematopoietic cell transplant, severe aplastic anemia